Key Events This Week
Jun 01: Stock hits 52-week low at Rs.25.6 amid sharp decline
Jun 02: Q4 FY26 results reveal mounting losses despite revenue growth
Jun 05: Week closes at Rs.27.62, down 8.97% for the week
Aug 11, 03:30 PM
BSE+NSE Vol: 19.2 k

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleThe next results date for Pharmaids Pharmaceuticals Ltd is scheduled for 12 August 2026....
Read full news article
Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 27 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Jun 01: Stock hits 52-week low at Rs.25.6 amid sharp decline
Jun 02: Q4 FY26 results reveal mounting losses despite revenue growth
Jun 05: Week closes at Rs.27.62, down 8.97% for the week

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 June 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended June 30 2026.
Appointment of M/s. V Mahendra & Associates as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27.
(12 Aug 2026)
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available